Table 4 Seroprevalence: development of antibodies from baseline to follow-up.
From: Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays
Baseline | Follow-up | p value | |
---|---|---|---|
Diasorin | 88 | 86 | n.s. |
Euroimmun | 90 | 73 | 0.0004 |
Abbott | 64 | 19 | 0.0001 |